Physician profile
Hershel Garner
NPI 1508839572
$2,358.14
in general payments reported to CMS, 2019-2025
47 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.36 · 2020: $75.23 · 2021: $178 · 2022: $291 · 2023: $750 · 2024: $679 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,744.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $243.24 | 2021-2025 | Enhertu, Datroway |
| Novartis Pharmaceuticals Corporation | $205.67 | 2021-2025 | |
| Puma Biotechnology, INC. | $191.93 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $190.29 | 2022-2025 | Keytruda, Lynparza |
| Janssen Biotech, INC. | $152.59 | 2021-2025 | Rybrevant, Darzalex, Imbruvica |
| Eisai INC. | $136.21 | 2021-2024 | |
| Tersera Therapeutics LLC | $96.87 | 2022-2023 | Xermelo, Zoladex |
| Regeneron Healthcare Solutions, INC. | $94.34 | 2022-2024 | Libtayo |
| Seagen INC. | $62.45 | 2020-2023 | Tukysa, Adcetris |
| Iovance Biotherapeutics, INC. | $47.37 | 2024-2025 | Amtagvi |
| Genmab U.S., INC. | $42.01 | 2024 | Epkinly |
| Ipsen Biopharmaceuticals, INC | $41.89 | 2022-2023 | Tazverik, Onivyde |
| Lilly USA, LLC | $39.54 | 2023-2024 | Verzenio, Jaypirca |
| G1 Therapeutics, INC. | $39.14 | 2022-2023 | Cosela |
| Exelixis INC. | $38.45 | 2023-2024 | Cabometyx |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hershel Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.